Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Scientia Pharmaceutica|August 26, 2017
Zytoprotektion mit Amifostin (Ethyol®) in der Chemotherapie: Meta-Analyse zum pharmakokinetischen Interaktionspotential mit ZytostatikaMartin Czejka, Johannes Schüller, Heidemarie Kletzl
Anti-Cancer Drugs|February 3, 2015
Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidineHeidemarie Kletzl, Mylene Giraudon, Patricia Sanwald Ducray, et al.
Statistical Methods in Medical Research|November 15, 2023
Estimating drug concentration-response relationships by applying causal inference methods for continuous point exposures and time-to-event outcomesSean Yiu, Qing Wang, Francois Mercier, et al.
International Journal of Pharmaceutics|July 29, 2017
Early pediatric formulation development with new chemical entities: Opportunities of e-tongue besides human taste assessmentLaura Isabell Immohr, Angela Dischinger, Peter Kühl, et al.
British Journal of Clinical Pharmacology|March 18, 2022
Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplamHeidemarie Kletzl, Hassan Ajmi, Izabela Antys, et al.
Expert Opinion on Investigational Drugs|June 28, 2021
Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in healthy volunteersMichael Derks, Sian Lennon-Chrimes, Andreas Guenther, et al.
Clinical Pharmacology and Therapeutics|August 4, 2021
Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular AtrophyYumi Cleary, Michael Gertz, Paul Grimsey, et al.
British Journal of Clinical Pharmacology|November 17, 2020
Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIOEkaterina Gibiansky, Claire Petry, Francois Mercier, et al.
Clinical Pharmacokinetics|May 6, 2023
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in ChildrenYumi Cleary, Heidemarie Kletzl, Paul Grimsey, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 16, 2014
A UGT2B10 splicing polymorphism common in african populations may greatly increase drug exposureStephen Fowler, Heidemarie Kletzl, Moshe Finel, et al.
Pageof 4